Prime Medicine, Inc. (Nasdaq:PRME)

Health Care/Life Sciences • Biotechnology

CIK 1894562

Company

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

Address
60 First Street
Cambridge, Massachusetts 02141-2300

Employees
234

Stock Info

Close
$2.3100

Day Range
2.1500 - 2.3250

52 Week Range
2.1200 - 8.5800

Average volume
1.08M

Short Interest
18.06M (02/14/25)

% of Float Shorted
34.78%

Market Cap
$302.98M

Revenue
N/A

Net Income
-$198.13M

2020 Sales Growth
N/A

Rev. per Employee
N/A

P/E Ratio
N/A

EPS
-$1.6972

Yield
0.00%

Dividend
$0.8000

Ex-Dividend Date
Sep 10, 2019

Key Executives

Board Of Directors

President, Chief Executive Officer & Director
Keith M. Gottesdiener

Director
Jeffrey D. Marrazzo

Independent Director
Michael Anthony Kelly

SEC filings

Date	Form	Event
13 Dec, 2024	S-3
9 Dec, 2024	4
9 Dec, 2024	4
9 Dec, 2024	4
22 Nov, 2024	SC 13D/A
12 Nov, 2024	SC 13G/A
12 Nov, 2024	10-Q
12 Nov, 2024	8-K
24 Oct, 2024	8-K
10 Oct, 2024	4
4 Oct, 2024	SC 13G
30 Sep, 2024	8-K
8 Aug, 2024	8-K
8 Aug, 2024	10-Q
14 Jun, 2024	4
14 Jun, 2024	4
14 Jun, 2024	4
14 Jun, 2024	4
14 Jun, 2024	4
14 Jun, 2024	4
14 Jun, 2024	4
12 Jun, 2024	8-K
7 Jun, 2024	4
21 May, 2024	DEFA14A
21 May, 2024	8-K
21 May, 2024	4
21 May, 2024	4
21 May, 2024	4
10 May, 2024	10-Q
10 May, 2024	8-K
29 Apr, 2024	DEFA14A
29 Apr, 2024	DEF 14A
29 Apr, 2024	ARS
19 Apr, 2024	PRE 14A
4 Mar, 2024	4
1 Mar, 2024	S-8
1 Mar, 2024	10-K
1 Mar, 2024	8-K
29 Feb, 2024	3
29 Feb, 2024	SC 13G/A
27 Feb, 2024	4
23 Feb, 2024	4
23 Feb, 2024	4
23 Feb, 2024	4
23 Feb, 2024	4
23 Feb, 2024	4
22 Feb, 2024	SC 13D
20 Feb, 2024	4
20 Feb, 2024	4
20 Feb, 2024	4
16 Feb, 2024	8-K
16 Feb, 2024	424B5
15 Feb, 2024	FWP
14 Feb, 2024	424B5
14 Feb, 2024	8-K
9 Feb, 2024	SC 13G/A
9 Feb, 2024	SC 13G/A
8 Jan, 2024	8-K
5 Jan, 2024	8-K
5 Jan, 2024	8-K
14 Nov, 2023	4
13 Nov, 2023	EFFECT
9 Nov, 2023	CORRESP
7 Nov, 2023	UPLOAD
3 Nov, 2023	8-K
3 Nov, 2023	10-Q
3 Nov, 2023	S-3
7 Aug, 2023	10-Q
7 Aug, 2023	8-K
26 Jul, 2023	4/A
25 Jul, 2023	4
22 Jun, 2023	4
16 Jun, 2023	4
16 Jun, 2023	8-K
16 Jun, 2023	4
16 Jun, 2023	4
16 Jun, 2023	4
16 Jun, 2023	4
16 Jun, 2023	4
15 Jun, 2023	4
13 Jun, 2023	4
12 Jun, 2023	144
9 Jun, 2023	4
7 Jun, 2023	4
5 Jun, 2023	144
2 Jun, 2023	4
31 May, 2023	4
30 May, 2023	144
26 May, 2023	4
24 May, 2023	4
22 May, 2023	4
18 May, 2023	4
18 May, 2023	144
17 May, 2023	8-K
16 May, 2023	4
12 May, 2023	3
12 May, 2023	4
12 May, 2023	4
11 May, 2023	DEFA14A
11 May, 2023	10-Q
11 May, 2023	8-K
11 May, 2023	8-K
10 May, 2023	4
8 May, 2023	144
28 Apr, 2023	DEFA14A
28 Apr, 2023	ARS
28 Apr, 2023	DEF 14A
20 Apr, 2023	4
20 Apr, 2023	4
4 Apr, 2023	4
4 Apr, 2023	4
4 Apr, 2023	4
4 Apr, 2023	4
4 Apr, 2023	4
4 Apr, 2023	4
10 Mar, 2023	8-K/A
9 Mar, 2023	10-K
9 Mar, 2023	S-8
9 Mar, 2023	8-K
13 Feb, 2023	SC 13G
10 Feb, 2023	SC 13G
9 Feb, 2023	SC 13G/A
7 Feb, 2023	SC 13G
9 Jan, 2023	8-K
14 Nov, 2022	10-Q
26 Oct, 2022	4
26 Oct, 2022	4
26 Oct, 2022	4
26 Oct, 2022	SC 13G
26 Oct, 2022	4
26 Oct, 2022	4
26 Oct, 2022	4
24 Oct, 2022	3/A
24 Oct, 2022	8-K
21 Oct, 2022	424B4	IPO completed
21 Oct, 2022	4
21 Oct, 2022	4
21 Oct, 2022	4
20 Oct, 2022	FWP
19 Oct, 2022	EFFECT
19 Oct, 2022	3
19 Oct, 2022	3
19 Oct, 2022	3
19 Oct, 2022	3
19 Oct, 2022	3
19 Oct, 2022	3
19 Oct, 2022	3
19 Oct, 2022	3
19 Oct, 2022	3
19 Oct, 2022	3
19 Oct, 2022	3
19 Oct, 2022	S-8
19 Oct, 2022	S-1MEF
19 Oct, 2022	CERT
19 Oct, 2022	3
19 Oct, 2022	3
19 Oct, 2022	3
19 Oct, 2022	3
19 Oct, 2022	3
19 Oct, 2022	SEC STAFF
17 Oct, 2022	FWP
17 Oct, 2022	CORRESP
17 Oct, 2022	S-1/A
17 Oct, 2022	CORRESP
17 Oct, 2022	8-A12B
17 Oct, 2022	CORRESP
14 Oct, 2022	UPLOAD
13 Oct, 2022	CORRESP
13 Oct, 2022	S-1/A
7 Oct, 2022	CORRESP
30 Sep, 2022	UPLOAD
23 Sep, 2022	S-1
5 Aug, 2022	DRS/A
6 May, 2022	DRS/A
11 Apr, 2022	SEC STAFF
8 Apr, 2022	DRS/A
8 Apr, 2022	DRSLTR
30 Mar, 2022	UPLOAD
25 Mar, 2022	DRS/A
25 Mar, 2022	DRSLTR
15 Mar, 2022	UPLOAD
7 Mar, 2022	DRS/A
7 Mar, 2022	DRSLTR
17 Feb, 2022	UPLOAD
4 Feb, 2022	DRS/A
4 Feb, 2022	DRSLTR
18 Jan, 2022	UPLOAD
12 Jan, 2022	DRS/A
20 Dec, 2021	DRS

Last update:2025-03-06 12:40:54.275176

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.